VCM
SAGE

Versant Capital Management’s Sage Therapeutics SAGE Stock Holding History

Versant Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-505
Closed -$4.61K – 2709
2025
Q2 		$4.61K Sell
505
-980
-66% -$7.21K ﹤0.01% 2181
2025
Q1 		$11.8K Buy
1,485
+1,249
+529% +$9.14K ﹤0.01% 1640
2024
Q4 		$1.28K Sell
236
-110
-32% -$672 ﹤0.01% 2145
2024
Q3 		$2.5K Buy
346
+259
+298% +$2.37K ﹤0.01% 1509
2024
Q2 		$945 Buy
87
+57
+190% +$730 ﹤0.01% 1687
2024
Q1 		$562 Hold
30
– – ﹤0.01% 1670
2023
Q4 		$650 Buy
30
+22
+275% +$436 ﹤0.01% 1620
2023
Q3 		$165 Sell
8
-7
-47% -$202 ﹤0.01% 1894
2023
Q2 		$705 Buy
+15
New +$746 ﹤0.01% 1727

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return